India launched Nafithromycin, its first indigenous Macrolide antibiotic, developed by Wockhardt with BIRAC support. Marketed as ‘Miqnaf,’ it treats drug-resistant pneumonia with a three-day course and tenfold efficacy, marking the first global breakthrough in its class in over 30 years.
Click to View More
© 2025 iasgyan. All right reserved